26.34 USD
↘ 0.29 (1.09%)AT CLOSE (11:59 AM EDT)
Oculis Holding AG Ordinary shares
OCSNASDAQ • USD
26.30
↗ 0.03 (0.11%)
POST MARKET (AS OF 05:39 PM EDT)
Post Market
AS OF 05:39 PM EDT
26.30
↗ 0.03 (0.11%)
Market: OPEN
Open?$26.51
High?$26.94
Low?$26.07
Prev. Close?$26.63
Volume?139.2K
Avg. Volume?N/A
VWAP?$26.52
Bid / Ask
Bid?$19.78 × 100
Ask?$31.35 × 100
Spread?$11.57
Midpoint?$25.57
Valuation & Ratios
Market Cap?1.5B
Shares Out?58.0M
Float?34.8M
Float %?66.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.